FTH (Faeth Therapeutics) Institutional Ownership: 3.82% (As of Jun. 24, 2026)


FTH Faeth Therapeutics Inc FTH
21 GF Score
Price $24.96
! 2 Warning Signs
View Full Analysis

What is Faeth Therapeutics Institutional Ownership?

Faeth Therapeutics FTH +0.70% 21 Institutional Ownership is 3.82% as of Jun. 24, 2026. GuruFocus rates FTH with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Faeth Therapeutics's institutional ownership is 3.82%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Faeth Therapeutics's Insider Ownership is 43.75%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Faeth Therapeutics's Float Percentage Of Total Shares Outstanding is 98.45%.

Faeth Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Faeth Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faeth Therapeutics Institutional Ownership Chart

Faeth Therapeutics Historical Data

The historical data trend for Faeth Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 1.39 1.39 1.39 1.05 1.04 1.05 11.63 11.81 11.91 11.91
FTH
21GF Score
Faeth Therapeutics Inc FTH
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Faeth Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.82% mean?
Faeth Therapeutics (FTH) has a Institutional Ownership of 3.82% as of Jun. 24, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Faeth Therapeutics and its competitors.
Is Faeth Therapeutics' Institutional Ownership too high?
Faeth Therapeutics' current Institutional Ownership is 3.82%. Overall, Faeth Therapeutics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Faeth Therapeutics' Institutional Ownership compare to NEUP and KYNB?
Faeth Therapeutics' Institutional Ownership of 3.82% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Faeth Therapeutics and its competitors. Faeth Therapeutics's current Institutional Ownership is 3.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faeth Therapeutics stock overvalued right now?
Faeth Therapeutics (FTH) has a current Institutional Ownership of 3.82%. The current Institutional Ownership is 3.82%. Faeth Therapeutics' overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Faeth Therapeutics (FTH), the current Institutional Ownership is 3.82% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Faeth Therapeutics Business Description

Address 701 Tillery Street No. 12, No.1010, Austin, TX, USA, 78702
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
21GF Score

Get the complete analysis for FTH

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.96
Price